| Product NDC: | 0095-0240 |
| Proprietary Name: | Bupap |
| Non Proprietary Name: | butalbital and acetaminophen |
| Active Ingredient(s): | 650; 50 mg/1; mg/1 & nbsp; butalbital and acetaminophen |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0095-0240 |
| Labeler Name: | ECR Pharmaceuticals Co., Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA089988 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19941201 |
| Package NDC: | 0095-0240-01 |
| Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (0095-0240-01) |
| NDC Code | 0095-0240-01 |
| Proprietary Name | Bupap |
| Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (0095-0240-01) |
| Product NDC | 0095-0240 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | butalbital and acetaminophen |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19941201 |
| Marketing Category Name | ANDA |
| Labeler Name | ECR Pharmaceuticals Co., Inc. |
| Substance Name | ACETAMINOPHEN; BUTALBITAL |
| Strength Number | 650; 50 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Barbiturate [EPC],Barbiturates [Chemical/Ingredient] |